BOT - Anything but charting, page-8658

What i'm looking forward to most is our sales story, Any SP talk is just noise until we start seeing results post expected FDA approval.

We should be able to present a telling tale of growth over the next 12 months given experience and relationship building for the sales team will develop, product exposure/word of mouth will have had some time to take root, and seasonality will also be in our favor come the next american summer.


Any potential TO before this period has elapsed would have to be at an unrealistic multiple to be worth considering given the potential on offer.